Table 1.
Description of the cancer patient population.
| Type of malignancy | Overall | US | BRZ | MEX | RUS | TUR |
|---|---|---|---|---|---|---|
| Solid malignancy, % of all cancer patients | 52 | 58 | 44 | 56 | 43 | 53 |
| Hematological malignancy, % of all cancer patients | 48 | 42 | 56 | 44 | 57 | 47 |
| Type of hematological malignancy | ||||||
| NHL, % of hematological malignancy patients | 40 | 37 | 44 | 46 | 36 | 43 |
| Follicular lymphoma, % of NHL patients | 45 | 55 | 46 | 38 | 43 | 36 |
| Diffuse large B-cell lymphoma, % of NHL patients | 55 | 45 | 55 | 62 | 57 | 64 |
| CLL, % of hematological malignancy patients | 26 | 24 | 33 | 24 | 28 | 20 |
| Other, % of hematological malignancy patients | 34 | 39 | 23 | 30 | 37 | 37 |
US = United States; BRZ = Brazil; MEX = Mexico; RUS = Russia; TUR = Turkey; NHL = non-Hodgkin’s lymphoma; CLL = chronic lymphocytic leukemia.